NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

There is a new authorisation date for Advent BioServices’ MIA(IMP) licence UK MIA(IMP) 54923.
The latest authorisation is dated 21 August 2025, while the previous one was 20 December 2024 – a relatively short interval between updates.
https://cms.mhra.gov.uk/mhra/mia/uk-miaimp-54923

The new authorisation (21 Aug 2025) extends Advent’s licence beyond manufacturing: it now also covers importation of investigational medicinal products (including cell therapy/live cell products) and QP-certified IMPs from approved countries.

[ 2.3 ] Other Importation Activities
[ 2.3.4 ] Other
Importation of QP-certified IMPs from a country on the approved country for import list.